People invited to undergo fecal immunochemical testing (FIT) were more likely to participate in colorectal cancer screening compared with those invited to undergo colonoscopy, the randomized ...

A mailed fecal immunochemical test (FIT) outreach followed by patient navigation for those with a positive test increased colorectal cancer (CRC) screening participation at 6 months compared with ...

Patient navigation and mailed outreach improved colorectal cancer screening rates in rural clinics, but follow-up colonoscopy participation remains low.

A patient navigation program significantly improved the odds that people would get a colonoscopy after receiving an abnormal ...

Average-risk patients can use fecal immunochemical testing (FIT) or Cologuard for a noninvasive way to screen for colon cancer, Kanth said. However, both methods have their flaws. Kanth said FIT ...

"We found that using patient navigators improved rates of colonoscopy follow-up and reduced time to follow-up among patients who had an abnormal fecal immunochemical test, or FIT test. This ...

A patient navigation program significantly increased follow-up colonoscopy among those with an abnormal FIT result. Ninety-four percent of patients who received navigation completed colonoscopy at ...

versus 71% sensitivity with fecal immunochemical test (FIT). 1 Fewer False Positives: 40% reduction compared to the original Cologuard test. 2 High Precancerous Lesion Detection: 43% sensitivity ...

Three of those are non-invasive. The first is the Fecal immunochemical test or FIT. “It requires no prep, no sedation, no dietary changes or anything,” said Griessel. “It’s sent home with ...

People invited to undergo FIT were more likely to participate in colorectal cancer screening compared with those invited to undergo colonoscopy. FIT was noninferior to colonoscopy for colorectal ...